- Home
- Publications
- Publication Search
- Publication Details
Title
CAR-T Therapies in Solid Tumors: Opportunities and Challenges
Authors
Keywords
-
Journal
Current Oncology Reports
Volume 25, Issue 5, Pages 479-489
Publisher
Springer Science and Business Media LLC
Online
2023-03-02
DOI
10.1007/s11912-023-01380-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
- (2022) Ya-Jui Lin et al. Frontiers in Immunology
- A Systematic Review on PD-1 Blockade and PD-1 Gene-Editing of CAR-T Cells for Glioma Therapy: From Deciphering to Personalized Medicine
- (2022) Mahdi Abdoli Shadbad et al. Frontiers in Immunology
- A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy
- (2022) Niaz Muhammad et al. Molecular Therapy-Oncolytics
- Hurdles to breakthrough in CAR T cell therapy of solid tumors
- (2022) Faroogh Marofi et al. Stem Cell Research & Therapy
- Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development
- (2022) Johannes Kast et al. CTS-Clinical and Translational Science
- In Pediatric Sarcomas, Less is Sometimes More
- (2022) Kilian E. Salerno et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
- (2022) Carlos Moreno et al. Biomedicines
- Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
- (2022) Jessica B Foster et al. Journal for ImmunoTherapy of Cancer
- Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
- (2021) Max Jan et al. Science Translational Medicine
- CAR T cells in solid tumors: challenges and opportunities
- (2021) Faroogh Marofi et al. Stem Cell Research & Therapy
- Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions
- (2021) Maral Adel Fahmideh et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A chimeric GM-CSF/IL18 receptor to sustain CAR T-cell function
- (2021) Shannon Lange et al. Cancer Discovery
- Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
- (2021) Yanan Wang et al. Frontiers in Immunology
- The quest to develop an effective therapy for neuroblastoma
- (2021) Praveen Bhoopathi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
- (2021) Nicholas A. Vitanza et al. NATURE MEDICINE
- Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission
- (2021) Jaume Mora et al. PEDIATRIC BLOOD & CANCER
- Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
- (2021) Rachael L. Terry et al. Cancers
- Fibroblast Activation Protein-α as a Target in the Bench-to-Bedside Diagnosis and Treatment of Tumors: A Narrative Review
- (2021) Lei Xin et al. Frontiers in Oncology
- Recent Advances in Pediatric Cancer Research
- (2021) Troy A. McEachron et al. CANCER RESEARCH
- Tuning the ignition of CAR: optimizing the affinity of scFv to improve CAR-T therapy
- (2021) Yanting Duan et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- GD2-specific chimeric antigen receptor-modified T cells for the treatment of refractory and/or recurrent neuroblastoma in pediatric patients
- (2021) Lihua Yu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Polymorphonuclear myeloid-derived suppressor cells impair the anti-tumor efficacy of GD2.CAR T-cells in patients with neuroblastoma
- (2021) Nicola Tumino et al. Journal of Hematology & Oncology
- CXCR2‐modified CAR‐T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma
- (2020) Guangna Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
- (2020) S. Depil et al. NATURE REVIEWS DRUG DISCOVERY
- Long-term Health Related Quality of Life in Pediatric Brain Tumor Survivors Treated with Proton Radiotherapy at <4 Years of Age
- (2020) Bree R Eaton et al. NEURO-ONCOLOGY
- Chimeric antigen receptor‐modified T‐cell therapy for platelet‐derived growth factor receptor α‐positive rhabdomyosarcoma
- (2020) Wei Xiao et al. CANCER
- Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
- (2020) Laura K. Donovan et al. NATURE MEDICINE
- Pediatric cancer mortality and survival in the United States, 2001‐2016
- (2020) David A. Siegel et al. CANCER
- VEGFR2 as a target for CAR T cell therapy of Ewing sarcoma
- (2020) Alexander Englisch et al. PEDIATRIC BLOOD & CANCER
- Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
- (2020) Meenakshi Hegde et al. Nature Communications
- Challenges and strategies of clinical application of CAR-T therapy in the treatment of tumors—a narrative review
- (2020) Weijing Li et al. Annals of Translational Medicine
- Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma
- (2020) Karin Straathof et al. Science Translational Medicine
- The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
- (2019) Katrin Mestermann et al. Science Translational Medicine
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
- (2019) Indu Ramachandran et al. Journal for ImmunoTherapy of Cancer
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
- (2018) Yuki Kagoya et al. NATURE MEDICINE
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Neurotoxicity Associated with a High-Affinity GD2 CAR—Response
- (2018) Sarah A. Richman et al. Cancer Immunology Research
- Teaching an old dog new tricks: next-generation CAR T cells
- (2018) Nicholas Tokarew et al. BRITISH JOURNAL OF CANCER
- Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
- (2017) Kevin Bielamowicz et al. NEURO-ONCOLOGY
- Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study
- (2017) Tabitha Cooney et al. NEURO-ONCOLOGY
- Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
- (2017) Nan Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment
- (2017) Kathrin Renner et al. Frontiers in Immunology
- HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma
- (2017) Nabil Ahmed et al. JAMA Oncology
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
- (2013) Meenakshi Hegde et al. MOLECULAR THERAPY
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Glypicans
- (2008) Jorge Filmus et al. GENOME BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started